Simultaneous 18F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer

scientific article published on 15 November 2018

Simultaneous 18F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3389/FONC.2018.00516
P932PMC publication ID6249271
P698PubMed publication ID30498693

P50authorTone F. BathenQ61104171
P2093author name stringArend Heerschap
Tone F Bathen
Tom Scheenen
Mattijs Elschot
Elise Sandsmark
Helena Bertilsson
Kirsten M Selnæs
Nassim Tayari
Morteza Esmaeili
P2860cites workEx vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomyQ87828465
18F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patientsQ89771987
Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.Q40227639
Simultaneous (68)Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer.Q40959799
Leucine and calcium regulate fat metabolism and energy partitioning in murine adipocytes and muscle cellsQ42829542
Optimal timing for in vivo 1H-MR spectroscopic imaging of the human prostate at 3T.Q46500550
Spatially matched in vivo and ex vivo MR metabolic profiles of prostate cancer -- investigation of a correlation with Gleason scoreQ46956034
A PET/MRI study towards finding the optimal [18F]Fluciclovine PET protocol for detection and characterisation of primary prostate cancerQ48243611
Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experienceQ48905216
Combined (18)F-Fluciclovine PET/MRI shows potential for detection and characterization of high-risk prostate cancerQ49547411
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomyQ50260314
The clinical safety, biodistribution and internal radiation dosimetry of [¹⁸F]fluciclovine in healthy adult volunteers.Q50491976
Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue anti-18F-FACBC in humans.Q51753150
Clinical PET Imaging in Prostate Cancer.Q51809435
Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI.Q52940451
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.Q52984458
Global cancer statistics, 2012Q27860501
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2Q29037908
Prostate Cancer Predictive Simulation Modelling, Assessing the Risk Technique (PCP-SMART): Introduction and Initial Clinical Efficacy Evaluation Data Presentation of a Simple Novel Mathematical Simulation Modelling Method, Devised to Predict the OutQ31117716
Improved method for accurate and efficient quantification of MRS data with use of prior knowledgeQ32172320
Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detectionQ33261888
Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease.Q34451031
Leucine Modulates Mitochondrial Biogenesis and SIRT1-AMPK Signaling in C2C12 MyotubesQ34454206
The role of leucine and its metabolites in protein and energy metabolismQ34488824
Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysisQ34681143
Improved volume selective (1) H MR spectroscopic imaging of the prostate with gradient offset independent adiabaticity pulses at 3 teslaQ35284153
High-Quality 3-Dimensional 1H Magnetic Resonance Spectroscopic Imaging of the Prostate Without Endorectal Receive Coil Using A Semi-LASER SequenceQ36410307
Prostate MRSI predicts outcome in radical prostatectomy patientsQ36879999
Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyaminesQ36949507
18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.Q37918311
Prostate cancer: multiparametric MR imaging for detection, localization, and staging.Q37935483
Update on the Gleason grading systemQ37952882
Mapping of prostate cancer by 1H MRSI.Q38114017
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.Q38160994
Metabolite ratios in 1H MR spectroscopic imaging of the prostateQ38184479
Multiparametric Magnetic Resonance Imaging in Prostate Cancer Management: Current Status and Future Perspectives.Q38479661
Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate.Q38595176
In vivo MR spectroscopic imaging of the prostate, from application to interpretationQ38975826
Regional distribution and kinetics of [18F]fluciclovine (anti-[18F]FACBC), a tracer of amino acid transport, in subjects with primary prostate cancerQ39508939
Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinomaQ40186415
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P921main subjectpositron emission tomographyQ208376
P304page(s)516
P577publication date2018-11-15
P1433published inFrontiers in OncologyQ26839986
P1476titleSimultaneous 18F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer
P478volume8

Search more.